©The Author(s) 2025.
World J Cardiol. Oct 26, 2025; 17(10): 110962
Published online Oct 26, 2025. doi: 10.4330/wjc.v17.i10.110962
Published online Oct 26, 2025. doi: 10.4330/wjc.v17.i10.110962
Table 1 Detailed characteristics of each included study (e.g., sample size, follow-up duration, mean age, comorbidities)
| Ref. | Study design | Country | Primary endpoints | No. of patients | Follow up duration | Age | Male (%) | Hypertension | CAD | DM | |||||||
| EVAR | Open | EVAR | Open | EVAR | Open | EVAR | Open | EVAR | Open | EVAR | Open | EVAR | Open | ||||
| von Allmen et al[16], 2014 | Observational study | United Kingdom | 30 days operative mortality, long-term survival (5 years), aortic related intervention | 354 | 264 | 5 years (maximum) | 5 years | 72.2 ± 3.5 | 70.3 ± 3.8 | 65.5 | 51.9 | NA | NA | NA | NA | NA | NA |
| Andrassy et al[17], 2011 | Observational study | Germany | Peri-operative morbidity and mortality, 1 year mortality and cumulative long term survival | 53 | 24 | 34 ± 35 (mean) | 53 ± 55 | 70 ± 10 | 67 ± 12 | 60 | 54 | 85% | 83% | 40% | 33% | 12% | 7% |
| Arnaoutakis et al[18], 2015 | Observational study | United States | 1 year all-cause mortality | 62 | 56 | 23.7 months (median) | 36.4 months | 67.6 ± 12.9 | 56.4 ± 14.3 | 53 | 68 | 89 | 77 | 34 | 9 | 16 | 11 |
| Bavaria et al[19], 2007 | Observational study | United States | Peri operative mortality and complications, middle term survival and reoperation rates | 140 | 94 | 25.8 ± 14.6 (mean) | 24.9 ± 12.8 | 70.5 ± 10.4 | 68.2 ± 10.2 | 57 | 51 | - | - | 49 | 36 | - | - |
| Brandt et al[20], 2004 | Observational study | Germany | 30 day mortality, peri operative morbidity | 22 | 22 | 30 days | 30 days | 68 ± 13 | 69 ± 11 | 68 | 59 | 64 | 77 | 36 | 32 | 14 | 18 |
| Chiu et al[28], 2019 | Observational study | United States | All-cause mortality | 2470 | 1235 | 4.53 ± 2.89 | 5.43 ± 6.90 | 72.97 ± 8.36 | 72.88 ± 7.52 | 57.6 | 57.5 | 78.9 | 79.5 | - | - | 21.5 | 19.4 |
| Desai et al[44], 2012 | Observational study | United States | Operative mortality, late survival | 106 | 45 | 59 ± 35.32 | 81 ± 71.99 | 74.3 ± 9.1 | 69.5 ± 11.1 | 57 | 40 | 88 | 89 | 21 | 6.7 | ||
| Dick et al[21], 2008 | Observational study | Switzerland | Peri operative mortality and morbidity within 30 days of treatment, cumulative long term survival, quality of life | 52 | 70 | 29 ± 16 | 37 ± 17 | 68.8 ± 10.1 | 61.6 ± 15.2 | 83 | 84 | 79 | 76 | 35 | 49 | 15 | 4 |
| Glade et al[22], 2005 | Observational study | Netherlands | In-hospital mortality, middle term survival | 42 | 53 | 15 | 26 | 67 | 67 | 62.1 | 62.1 | 86 | 75 | - | - | 12 | 6 |
| Goodney et al[45], 2011 | Observational study | United States | - | 2433 | 11565 | - | - | 75.9 ± 6.29 | 73.8 ± 5.49 | 58.7 (95% CI: 567-60.7) | 55.4 | - | - | - | - | NA | NA |
| Gopaldas et al[23], 2010 | Observational study | United States | In-hospital mortality | 2563 | 9106 | NA | NA | 69.5 ± 12.7 | 60.2 ± 14.2 | 59.4 | 68 | - | - | - | - | 13.7 | 9.4 |
| Hughes et al[30], 2014 | Observational study | United States | Mortality | 712 | 8255 | Short term | - | 71 ± 11.14 | 62.33 ± 14.83 | 61.3 | 65.6 | - | - | - | - | 13.2 | 8.3 |
| Karimi et al[24], 2012 | Observational study | United States | In-hospital and late mortality, endo-leak and re-intervention rates | 28 | 29 | 26.9 ± 14 | 42.6 ± 19.8 | 73.2 ± 9.7 | 62.3 ± 12.2 | 57.1 | 65.5 | 78.6 | 89.7 | 32.1 | 27.6 | 10.7 | 34.5 |
| Kieffer et al[31], 2009 | Observational study | France | - | 52 | 121 | Short term | - | 69.3 ± 12.5 | 59.4 ± 13.7 | 78.8 | 82.6 | 71.2 | 77.7 | 34.6 | 24.8 | 5.8 | 4.1 |
| Lee et al[25], 2015 | Observational study | Korea | 30-day and late mortality | 114 | 53 | 36 ± 26 | 36 ± 26 | 65.5 ± 12.9 | 60.1 ± 15.9 | 76.3 | 69.8 | 73.7 | 75.5 | 11.4 | 13.2 | 8.8 | 13.2 |
| Matsumura et al[32], 2014 | Observational study | Denmark | - | 158 | 70 | 5 years (maximum) | 5 years | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| Ogawa et al[35], 2021 | Observational study | United States | 30-day and long term all cause mortalities | 79 | 39 | 828 ± 1258 (days) | 1048 ± 1591 (days) | 70.4 ± 12.7 | 64 ± 13.6 | 60.8 | 74.4 | 86.1 | 69.2 | 15.2 | 12.8 | 8.9 | 7.7 |
| Orandi et al[26], 2009 | Observational study | United States | In-hospital mortality | 267 | 763 | NA | NA | 69.9 ± 20.9 | 66.1 ± 21.3 | 69.2 | 66.1 | 76.2 | 64.3 | NA | NA | 7.6 | 11 |
| Orelaru et al[34], 2023 | Observational study | United States | - | 120 | 120 | 8.80 ± 7.13 years | 4.0 7 ± 3.68 | 64 ± 14.07 | 65 ± 10.37 | 64 | 66 | 91 | 88 | 18 | 25 | 13 | 13 |
| Patel et al[33], 2008 | Observational study | United States | - | 52 | 41 | 33.1 ± 36.9 (maximum follow up 12 years) | 33.1 ± 36.9 | 80.6 ± 4.0 | 76.8 ± 1.8 | 50 | 70.7 | 78.9 | 80.5 | 55.8 | 43.9 | 13.5 | 4.9 |
| Stone et al[27], 2006 | Observational study | United States | Peri-operative mortality, actuarial middle-term survival, freedom from re-intervention | 105 | 93 | 22 ± 16.83 months | - | 70 ± 14.3 | 70.8 ± 9.8 | 62.9 | 54.8 | NA | 84.9 | NA | NA | NA | NA |
- Citation: Khawar M, Ali U, Rasheed MA, Rasheed AB, Shah SA, Zain S, Saifullah M, Mubarika M, Hadeed Khawar MM, Iqbal T, Ghuman SI, Rana I, Pathak P. Thoracic endovascular vs open surgical repair in descending thoracic aortic aneurysms: A systematic review and meta-analysis. World J Cardiol 2025; 17(10): 110962
- URL: https://www.wjgnet.com/1949-8462/full/v17/i10/110962.htm
- DOI: https://dx.doi.org/10.4330/wjc.v17.i10.110962